Three engineering research projects at The University of Texas at Austin-a protein therapy for liver cancer, an antibody therapy for cancer treatment and an immunity booster to respond to cancer-received $3.3 million from the Cancer Prevention and Research Institute of Texas.
Biomedical Engineers Get $11.6 Million from National Cancer Institute to Offer Non-traditional Cancer Research Approaches
The University of Texas at Austin Department of Biomedical Engineering is among a consortium of leading research entities from across the United States selected to receive up to $11.6 million from the National Cancer Institute (NCI) to establish a center to conduct innovative cancer research.
The University of Texas at Austin has licensed technology for a probe that would quickly scan skin to detect skin cancer to DermDx Inc., a company based in Fresno, Calif.
Nicholas A. Peppas was elected today to the Institute of Medicine (IOM) of the National Academy of Sciences, becoming the first faculty member from The University of Texas at Austin to receive this honor—the highest recognition a scientist or engineer in the medical sciences can receive in the United States.
A novel delivery system that could lead to more efficient and more disease-specific vaccines against infectious diseases has been developed by biomedical engineers at The University of Texas at Austin.
Technology that can determine the concentration of nanomaterials in living tissue has been licensed by The University of Texas at Austin to Houston-based nanoTox Inc.
Assistant Professor James Tunnell has been awarded a Phase II Early Career Award from the Wallace H. Coulter Foundation to continue the development and testing of a device that uses light to detect skin cancer without the need for an invasive biopsy procedure.
A biomedical engineering assistant professor at The University of Texas at Austin has been awarded a $1.5 million National Institutes of Health/National Cancer Institute grant to conduct nanoparticle cancer research.
A biomedical engineering professor at The University of Texas at Austin is using a concept called "grid computing" to allow the average person to donate idle computer time in a global effort to fight cancer.
Insulin pills to replace the injections necessary for those suffering from diabetes appear closer to reality through new research by chemical and biomedical engineers at The University of Texas at Austin.